Image by Scott Graham

Prof. ΙΩΑΝΝΗΣ Κ. ΤΡΙΑΝΤΑΦΥΛΛΙΔΗΣ M.D., Ph.D., F.E.B.G.H., M.A.C.G. 
ASSOCIATE PROFESSOR, “GR. T. POPA” UNIVERSITY OF MEDICINE & PHARMACY, IASI, ROMANIA

PAPERS PUBLISHED IN INTERNATIONAL MEDICAL  JOURNALS WITH IMPACT FACTOR

Περιλαμβάνουν συνολικώς 251 επιστημονικές δημοσιεύσεις εκ των οποίων:
•    130 είναι πλήρεις ερευνητικές εργασίες (papers), short reports ή letters to the editor που δημοσιεύθηκαν σε διεθνή περιοδικά με impact factor. 
•    112 είναι πλήρεις ερευνητικές εργασίες ή letters to the editor οι οποίες δημοσιεύθηκαν σε τόμους πρακτικών διεθνών συνεδρίων ή αγγλοφωνα διεθνή περιοδικά μετά peer review, τα οποία όμως δεν περιλαμβάνονται στο PubMed (εκτός του Annals of Gastroenterology το οποίο περιελήφθη προ τριετίας) αν και περιλαμβάνονται σε πολλές άλλες διεθνείς βάσεις δεδομένων. 
•    Ο συνολικός αριθμός των περιοδικών στα οποία δημοσιεύθηκαν οι εργασίες μου είναι 46 και είναι τα ακόλουθα κατ’ αλφαβητική σειρά. 

No    Authors    Title    Journal

  1. J. Economidou, O. Manousos, D. Trichopoulos, J. Triantafillidis, T. Tsicricas, G. Merikas.    Serum immunoglobulins in a rural and urban population of Greece with special reference to immunoglobulin A. J Clinical Pathology 1979, 32:1140-1143.

  2. Papanastasiou-Diamanti A, PA Siskos, T.P. Hadjioannou, J.K. Triantafilidis.    Enzymic fluorometric determination of the individual bile acids in blood serum.    Analytica Chimica Acta 1984;160:243-248.

  3. Emmanoulidis, D. Tsantoulas, J. Triantafillidis, O. Manousos, L. Gregoropoulos.  Endomitriosis of the sigmoid colon Gastrointest Endoscopy 1984;30:373-374

  4. O. Manousos, J. Economidou, C. Papadimitriou, J. Κ. Triantafillidis, N. Konstantinidou, A. Stathopoulos.    Malabsorption associated with non-malignant immunoproliferative small-intestinal disease. Digestion  1987;36:182-188

  5. J. K. Triantafillidis, J. Economidou, O. Manousos, P. Efthimiou. Cutaneous delayed hypersensitivity in Crohn’s disease and ulcerative colitis.    Dis Colon Rectum 1987; 30:536-539.

  6. J. K. Triantafillidis, K. Tsamakidis, N. Barboulis, B. Seitanidis.    Acute leukaemia following ulcerative colitis. A case report.    Am J Gastroenterol 1987;82:1334-1336

  7. Lianidou ES, Papanastasiou-Diamandi A, Siskos P (Acknowledgment J.K. Triantafilidis).    Enzymic fluorimetric determination of sulphated and non-sulphated primary bile acids in urine, using a rapid solvolysis technique    Analyst 1988;113:1459-1463

  8. Α. Emmanouilidis, O. Manousos, J. K. Triantafilidis, C. Papadimitriou. Ulcerative colitis in Greece, course and prognosis.    Digestion 1988;39:181-186

  9. J. K. Triantafillidis, K. Manoussakis, E. Papavassiliou. Ornidazole in the treatment of active Crohn’s disease.    Am J Gastroenterol 1988,83 :892-893.

  10. O. Manousos, J. K. Triantafillidis, A. Emmanouilidis, C. Papadimitriou.    Ulcerative colitis in Greece. Epidemiologic and clinical data.    Scand J Gastroenterol 1989;24(Suppl 170):25-26.

  11. J. K. Triantafillidis, K. Manoussakis, C.Tsa-faras, A. Koutsorizof.    Coexistence of thyreotoxicosis and exacerbation of ulcerative colitis.    Am J Gastroenterol 1990,85:908-910

  12. K. Manoussakis, J. K. Triantafillidis, P. Dadioti, Ε. Papavas-siliou, V. Lissaios.    The role of computed tomography in the assessment of patients with abdominal actinomycosis.    Am J Gastroenterol  1990,85:213-214

  13. J. K. Triantafillidis, P. Dadioti, D. Nicolakis, E. Merikas.    High doses of 5-aminosalicylic acid enemas in chronic radiation proctitis. Comparison with betamethazone enemas.    Am J Gastroenterol 1990;85:1537-1538

  14. J. K. Triantafillidis, D. Nicolakis, G. Mountaneas, E. Pomonis.    Treatment of diversion colitis with 5-aminosalicylic acid enemas. Comparison with betamethazone enemas.    Am J Gastroenterol 1991; 86:1552-1553

  15. J. Pagidis, K. Vonorta, J.K. Triantafillidis, G. Mountaneas, P. Koutsioumba, G. Protoulis.    Clinical validity of the determination of 3 tumor markers (CA 19-9, CEA, aFP), in the serum and gastric juice of patients with benign and malignant stomach disorders.    Hepatogastroenterology 1992;39 (Suppl II):158-161.

  16. J.K. Triantafillidis, P. Cheracakis, A. Zerva-cakis, M. Theodorou.    Coexistence of hypethyroidism and ulcerative colitis: Report of 4 cases and a review of the literature.    Ital J Gastroenterol 1992; 24:494-497.

  17. E. Pomonis, J. K. Triantafillidis, M. Tjenaki, A. Emmanouilidis.    Eales΄ disease and ulcerative colitis in the same patient. Report of a case.    Am J Gastroenterol 1992;87:1531-1532.

  18. J. K. Triantafillidis, M. Tsardi, J. Jacovidou.    Lipohyperplasia of ileocecal valve contiguous with adenocarcinoma of the gallbladder    Am J Gastroenterol 1992;87:1892-1893

  19. J. K. Triantafillidis, P. Kosmidis, S. Kottaridis.    Familial stomach cancer: report of a case and review of the literature.    Am J Gastroenterol1993;88:1789-1790.

  20. K. Papatheodorou, J. K. Triantafillidis, M. Kogevinas, K. Manoussakis, D. Nicolakis, E. Merikas. Cutaneous delayed hypersensitivity in patients with colorectal cancer: application of multitest.    Ital J Gastroenterol 1993;26:12-15.

  21. J. K. Triantafillidis, P. Roussou, O. N. Manousos, P. Dadioti, D. Nicolakis.    Ulcerative colitis and Sjogren’s syndrome in the same patient: Report of two patients and a review of the literature.    Ital J Gastroenterol 1994;26:299-302

  22. J.K. Triantafillidis, G. Kottaras, H.Crisso-choou, S. Sgouros, P. Cheracakis. Nutritional support in patients with a betalipoproteinemia.     Nutrition 1994,10:346-349.  (Editorial comment on page 349)

  23. J.K. Triantafillidis, J. Vekini D. Nicolakis, A. Emmanouilidis.    Ethanol induced proctitis: another kind of chemical proctitis.    Am J Gastroenterol 1994;89:1270-1271.

  24. Govosdis B, J. K. Triantafillidis, H. Chrissochoou, S. kalogeracos, P. Perdicouris.    Effect of calcium intake on the incidence of sporadic colorectal polyps.    Am J Gastroenterol 1994;89:952-953.

  25. P. Benakis, D. Nicolakis, J. K. Triantafillidis.    Successful endoscopic removal of part of a T-tube from the common bile duct.    Endoscopy 1994 ;26 :756

  26. J.K. Triantafillidis, K. Papatheodorou, M. Kogevinas, K. Manoussakis, D. Nicolakis.    Prognostic factors affecting the survival of operated patients with colorectal cancer: signify-cance of delayed hypersensiti-vity skin reactions and nutritional status.    Ital J Gastroenterol 1995; 27:419-424.

  27. J. K. Triantafillidis.    Gastrointestinal manifestations of Sjogren’s syndrome.    Am J  Gastroenterol 1995;90:1541.

  28. J.K. Triantafillidis, D. Nicolakis, A. Emmanouilidis, A. Antoniou, K. Papatheodorou.    Ornidazole in treatment of active Crohn’s disease: short-term results.    Ital J Gastroenterol 1996, 28:10-14. Lowenfels A.B, Eugene MP, Elitsur Y, and the International Hereditary Pancrea-titis Study Group (J. K. Triantafillidis, co-investigator) Hereditary pancreatitis and the risk of pancreatic cancer.    J Natl Cancer Inst 1997,89: 442-446.It was categorized among  the top 20 papers published on pancreatitis.

  29. J.K. Triantafillidis, E. Pomonis, A. Em-manouilidis, O.N. Ma-nousos, E. Merikas, C. Tsitsa, E. Hatziandreou.    Surgery for ulcerative colitis in Greece: clinicoepidemiological features and long-term outcome of 69 consecutive patients.    Hepatogastroenterology  1998,45:961-968.

  30. J. K.Triantafillidis, A. Emmanouilidis, O. N. Manousos, E. Po-monis, C. Tsitsa, P. Cheracakis, Ch. Barbatzas.Ulcerative colitis in Greece: clinicoepidemiological data, course and prognostic factors in 413 consecutive patients.    J Clin Gastroenterol. 1998;27:204-210

  31. J. K.Triantafillidis, Kottaras G, Sgouros S, Cheracakis P, Driva G. Konstandellou E, Parasi A. Choremi H. Samouilidou E.    A-β-lipoproteinemia: clinical and laboratory features, therapeutic manipulations and follow-up study of three subjects of a Greek family.    J  Clin  Gastroenterol  1998;26:207-211.

  32. J.K. Triantafillidis.    Gastric cancer    Hepatogastroenterology  1998,45:1930-1934.

  33. J. K.Triantafillidis, Aik. Antoniou, A. Emmanouilidis, D. Nicolakis.    Ornidazole in the prevention of recurrence of Crohn’s  disease.    Ital J Gastroenterol Hepatol1998,30:446-447.

  34. J.K. Triantafillidis, Ch. Barbatzas, P. Cheracakis, D. Tsikalakis, P. Dadioti, S. Ladas.    Helicobacter pylori infection and gastric juice total phospholipid concentration in patients with bleeding peptic ulcer.    Am J Gastroenterol 1998, 93:2642-2643.

  35. J.K. Triantafillidis, P. Cheracakis, I. Hereti, N. Argyros, E. Karra.    Acute idiopathic pancreatitis complicating Crohn’s disease: Favorable response to Infliximabe treatment.    Am J Gastroenterol 2000;95:3334-3336.

  36. J. K.Triantafillidis, A. Emmanouilidis, O. Manousos, D. Nicolakis, M. Kogevinas.    Clinical patterns of Crohn’s disease in Greece: a follow-up study of 155 cases.    Digestion 2000;61:121-128.

  37. J.K. Triantafillidis,  A. Emmanouilidis, D. Nicolakis, T. Ifantis, P. Cheracakis, E. Merikas.    Crohn’s disease in the elderly: clinical features and long-term outcome of 19 Greek patients.    Dig Liver Dis 2000;32:498-503.

  38. J. K.Triantafillidis, A. Emmanouilidis, D. Nicolakis, P. Cheracakis, M. Kogevinas, E. Merikas, N. Argyros.    Surgery for Crohn’s disease in Greece.    Hepatogastroenterology 2001;48:1072-1077.

  39. J.K. Triantafillidis, A. Emmanouilidis, E. Pomonis, P. Chera-cakis, E. Merikas, D. Nicolakis, N. Argyros.    Ulcerative colitis in the elderly: clinical patterns and outcome in 51 Greek patients.    J. Gastroenterol2001;36: 312-316.  

  40. Editorial on the same issue of J. Gastroenterol

  41. J.K. Triantafillidis, D. Nicolakis, A. Antoniou.    Absence of toxicity of ornidazole after a 10-yr continuous daily use for Crohn’s disease.    Am J Gastroenterol 2001;96:254-255.

  42. J.K. Triantafillidis, Giolla Driva, P. Chera-cakis, Ch. Barbatzas, H. Konstantellou.    Increased number of CD5+ and CD20+ B lymphocyte subpopulation in Gastroen-terology endoscopy staff.    Am J. Gastroenterol 2001;96:617-619.

  43. J.K. Triantafillidis, Th. Hyphantis, G. Driva, P. Cheracakis, Ch. Barbatzas.H. Konstantellou.    Ornidazole treatment in normal subjects reduces serum levels of C3.    Dig Liver Dis 2001;33:302-303.

  44. J.K. Triantafillidis, P. Cheracakis    Severe infection by varicella virus in an adult with ulcerative colitis: favourable response to acyclovir treatment.    Dig Liver Dis 2002;34:383-384

  45. I. Andreadou, A. Papalois, J.K. Triantafillidis, M. Demonakou, V. Govosdis, M. Vidali, E. Anagnostakis, P.N. Kourounakis.    Beneficial effect of a novel nonsteroidal anti-inflammatory agent with basic character and antioxidant properties on experimental colitis in rats.    Eur J Pharmacol  2002;441:209-214.

  46. J.K. Triantafillidis, A. Gikas, Th. Hyphantis, et al.    Helicobacter pylori infection in hospital workers over a five-year period : correlation with demographic and clinical parameters.    J Gastroenterol 2002;37: 1005-1013. (Editorial on page 1092 of the same issue of the J. Gastroenterol)

  47. J.K. Triantafillidis, P. Cherakakis, Maria Sklavaina, Kalliopi Apostolopoulou.    Favorable response to Infliximab treatment in a patient with active Crohn’s disease and pyoderma gangrenosum.    Scand J Gastroenterol 2002;37:863-865.\

  48. J.K. Triantafillidis, Th. Hyphantis, P. Cheracakis, A. Antoniou, M. Sklavaina.    Suicide as an outcome on patients with inflammatory bowel disease.    Am J Gastroenterol 2002;97:1066-1068.

  49. J.K. Triantafillidis, P. Cheracakis. Ref. Fefferman et al    «Recurrence» of chronic pancreatitis appearing on a patient with Crohn’s disease.    Am J Gastroenterol 2002; 97:761-762.

  50. J.K. Triantafillidis, P. Cheracakis, E. Konstantellou, T. Hyphantis.    Increased serum levels of the tumor marker CA 15-3 on patients with pernicious (Biermer) anemia.    Oncology 2002;63:306-307.

  51. Μ. Michalatos, I. Danielidis, J. Belo-gianni, E. Harokopos, E. Papadopoulou, G. Kallimanis, M. Tsiava, J.K. Triantafillidis, et al   Novel mutations of the APC gene in familial adenomatous polyposis in Greek patients.   Cancer Genetics & Cytogenetics 2003;141:65-70.

  52. Mihalatos M, Apessos A, J.K. Triantafillidis, et al.  Evaluation of dHPLC in mutation screening of the APC gene in a Greek FAP cohort.    Anticancer Res 2003;2691-2695.

  53. J.K. Triantafillidis, E. Merikas, V. Govosdis, E. Konstantellou, P. Cheracakis, C. Barbatzas, D. Tzourmakliotis, G. Peros.   Increased serum levels of Growth Hormone and Gastrin in patients with gastric and large bowel cancer.   Hepatogastroenterology 2003;50: Suppl 2:cclvi-cclx.

  54. J.K. Triantafillidis, D. Tzourmakliotis, G. Peros, E. Merikas, C. Barbatzas, P. Cheracakis, A. Gikas, E. Konstantellou.    Serum gastrin levels in patients with inflammatory bowel disease.    Hepatogastroenterology 2003;50: Suppl 2:cccxv-cccxvii.

  55. J.K. Triantafillidis, D. Georgakopoulos, A. Gikas, E. Merikas, G. Peros, K. Sofroniadou, P. Cheracakis, M. Sklavaina, G. Tzanidis, E. Konstantellou.    Relation between Helicobacter pylori infection, thyroid hormone levels and cardiovascular risk factors on blood donors.    Hepatogastroenterology 2003;50: Suppl 2:cccxviii-cccxx

  56. J.K. Triantafillidis, P. Cheracakis, G. Peros, E. Merikas.    Acute pancreatitis may precede the clinical manifestations of Crohn’s disease.    Am J Gastroenterol 2003;99,1210-1211.

  57. J.K. Triantafillidis, A. Gikas.    Response to Dr Guslandi.    Am J Gastroenterol 2003; 98:2571-2572.

  58. J.K. Triantafillidis,  A. Gikas, N. Apostolidis, E. Merikas, G. Peros, H. Mallas.    The low prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease could be attributed to previous antibiotic treatment.    Am J Gastroenterol 2003;99:1213-1214.

  59. J.K. Triantafillidis, P. Cheracakis.    Diagnostic evaluation of patients with early gastric cancer .A literature review.   Hepatogastroenterology 2004;51:618-624.

  60. Gikas A, J.K. Triantafillidis, N. Apostolidis, E. Mallas, G. Peros, G. Androulakis.    Relation of smoking, coffee and alcohol consumption with seroconversion to Helicoba-cter pylori – A longitudinal study in hospital workers.  J Gastroenterol Hepatol 2004;19:927-933

  61. T. Hyphantis, J.K. Triantafillidis, K. Antoniou, Pappa S, Mantas C, Kaltsouda A, Cheracakis P, Ala-manos Y, Manousos ON, Mavreas VG.    Defense styles and ego mechanisms of defence in patients with Crohn’s disease.    J Gastroenterol  2005;40:24-30.

  62. Triantafillidis J.K., G. Kottaras, G. Peros, E. Merikas, A. Gikas, N. Kondylis, Evangelia Konstantellou.    Endocrine function in abetalipoproteinemia: a study of a female patient of Greek origin    Ann Ital Chir 2004; LXXV,6:683-690.

  63. M. Michalatos, A. Apessos, Hans Dauwerse, V. Velissariou, A. Psychias, A. Koliopanos, K. Petropoulos, J.K. Triantafillidis, I. Danielididis, G. Fount-zilas, N. J Agnantis, G. Nasioulas.    Rare mutations predisposing to familial adenomatous polyposis in Greek FAP patients.    BMC Cancer 2005;5:40.

  64. A. Apessos, M. Michalatos, I. Danielidis, G. Kallimanis, N.J. Agnantis, J.K. Triantafillidis, G. Fountzilas, P.A. Kosmidis, E. Razis, V.A. Georgoulias, G. Nasioulas.  hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients.    Br J Cancer 2005;92:396-404.

  65. Archimandritis A, V. Nikolopoulou, G. Kou-klakis, E. Paraskevas, A. Avgerinos, E. Tsianos, J.K. Triantafillidis. Effects of rabeprazole on early relief in gastroesophageal reflux disease: The Hellenic rabeprazole study group surveillance study.    Current Medical Research and Opinion. 2005;21:603-610. 

  66. J.K. Triantafillidis, A. Papalois, A. Parassi, E. Anagnostakis, S. Burnazos, A. Gikas, E.Merikas, E. Douzinas, M. Karagianni, H. Sotiriou.    Favorable response to subcutaneous administration of Infliximab in experimental colitis in rats.    World J Gastroenterol 2005;11:6843-6847.

  67. Aikaterini Parasi, J.K. Triantafillidis, C. Barbatzas, A. Karakosta, N. Kondylis, H Sotiriou.  Coexistence of Crohn’s disease and inflammatory fibroid polyp of the small bowel: report of a case and review of the literature.    Ann Ital Chir 
    2005;76:395-9.

  68. Hyphantis T, A. Kaltsouda, J.Κ.Triantafillidis, Platis O, Karadagi S, Christou K, Mantas C, Argyropoulos A.    Personality correlates of adherence to type 2 diabetes regimens.    Intern J Psychiatry Med 2005;35:103-107.

  69. Economidou J, O.N. Manousos, J.K Triantafillidis, Vaslamatzis MM, Zafiropoulou R, Papadakis T.    Immunoproliferative small intestinal disease (IPSID) in Greece: presentation of 13 cases including two from Albania. Eur J Gastroenterol Hepatol 2006;1029-1038

  70. Tsiambas E, Karαmeris A, Lazaris AC, Talieri M, JK Triantafillidis, Cheracakis P, Manaios L, Gerontopoulos K, Patsouris E, Lygidakis NJ.    EGFR alterations in pancreatic ductal adenocarcinoma: a chromogenic in situ hybridization analysis based on tissue microarrays.    Hepatogastroenterology 2006;53:452-457.

  71. A.C. Kaliora, M.G. Stathopoulou, J.K. Triantafillidis, G.V.Z. Dedoussis, N.K. Andrikopoulos    Chios mastic treatment of patients with active Crohn’s disease. World J Gastroenterol 2007;13:748-753

  72. J.K. Triantafillidis, F. Georgopoulos, G. Malgarinos, A. Gikas.    Tuberculin test in inflammatory bowel disease    Inflamm Bowel Dis 2007;13:1451.

  73. A. Kaliora, M. Stathopoulou, J.K. Triantafillidis, G. Dedoussis, N. Andrikopoulos.   Alterations in the function of circulating mononuclear cells derived from patients with Crohn’s disease treated with mastic.  World J Gastroenterol 2007;13:6031-6036.

  74. Malgarinos G, Gikas A, Delicha E, Stamataki A., Georgopoulos F, Papadimitriou A, Stanciu C, J.K. Triantafillidis.  Pregnancy and inflammatory bowel disease: a prospective case-control study.     Rev Med Chir Soc Med Nat Iasi  2007;111:613-619

  75. J.K. Triantafillidis, G. Mantzaris, A. Stamataki, G. Malgarinos, A. Gikas.    Complete remission of severe scleritis and psoriasis in a patient with active Crohn’s disease using Modulen IBD as an exclusive immunomodulating diet. J Clin Gastroenterol 2008;42:550-551. 

  76. J.K. Triantafillidis, Flora Zervou-Valvi  E. Merikas, G. Peros, Οθ. Galitis, A. Gikas.     Granulomatous cheilitis associated with exacerbations of Crohn’s disease: a case report    J Med Case Reports 2008;2:60

  77. Apessos A, Papadopoulou E, Belogianni I, Baratsis S, Triantafillidis J.K., Kosmidis P, Karydas E, Briasoulis E, Pisiotis C, Papazisis K, Nasioulas G    Inherited cancer predisposition syndromes in Greece.   Anticancer Research 2008;2(2B):1341-1347

  78. J.K. Triantafillidis, G. Malgarinos, C. Iatrou, A. Hatzivassiliou, G. Peros.   Coexistence of medallury sponge kidney and ulcerative colitis in the same patient: Long-term follow-up    Rev Med Chir Soc Med Nat Iasi 2009; 113:438-441.

  79. J.K. Triantafillidis, E. Merikas, G. Malgarinos, V. Panteris, G. Peros    Acute idiopathic pancreatitis preceding diagnosis of Crohn’s disease: description of three cases    Rev Med Chir Soc Med Nat Iasi 2009;113:97-102.

  80. Triantafillidis J.K., Nasioulas G, Kosmidis PA.    Colorectal cancer and inflamma-tory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.Anticancer Res 2009;29:2727-2737.

  81. V. Panteris, A. Karakosta, E. Merikas, G. Peros, J.K. Triantafillidis.   Gastric outlet obstruction due to megalovirus infection in an  ecurr-compromised patient J. Med Case Reports 2009;3:280-285.

  82. Karagianni V,  Merikas E, Georgopoulos F, Gikas A, Athanasopoulos N, Malgarinos G, Peros G, Triantafillidis J.K.    Risk factors for colorectal polyps: findings from a Greek case-control study. Rev Med Chir Soc Med Nat Iasi. 2010;114:662-670

  83. Triantafillidis J.K., Mantzaris G, Karagiannis J, Papavasilliou E, Papatheodoridis G, Fouskas J, Malgarinos G, Gikas A, Papamichael K, Mathou N, Symboulakis E, Karamanolis D.    Similar response to adalimumab in patients with active Crohn’s disease either naive to biologic agents or with prior loss of response or intolerance to infliximab. Rev Med Chir Soc Med Nat Iasi. 2010;114:85-90

  84. Triantafillidis J.K., Nadia el-F, Fostira F, Terzoudi G, Fouskas J, Pinis S.    Turner’s syndrome, autoimmune thyroiditis, and Crohn’s disease in the same patient: a combina-tion emphasizing the role of X-chromosome in inflammatory bowel disease patients. Inflamm Bowel Dis. 2010;16:1088-1089.

  85. Turunen K, Tsouvelakidou E, Nomikos T,  Mountzouris KC, Karamanolis D, Triantafillidis J.K., Kyriacou A.    Impact of beta-glucan on the faecal microbiota of polypectomized patients: A pilot study. Anaerobe.  2011;17:403-6. 

  86. Triantafillidis J.K., Merikas E, Georgopoulos F. Current and emerging drugs for the  treatment of inflammatory bowel disease. Drug Des Devel Ther. 2011 ;5 :185-210. DoveMedical Press  Total Views : 19172 Update (December 10, 2019)

  87. Gioxari A, Kaliora AC, Papalois A, Agrogiannis G, Triantafillidis J.K., Andrikopoulos NK.  Pistacia lentiscus Resin Regulates Intestinal Damage and Inflammation in Trinitrobenzene Sulfonic Acid-Induced Colitis.    J Med Food. 2011;14:1403-11.

  88. P. Clave,  M. Acalovschi, J. K. Triantafillidis, Y. P. Uspensky, C. Kalayci, V. Shee, J. Tack    Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome    Alimentary  Pharmacol Ther 2011-06-04

  89. Triantafillidis J.K., Kougioumtzian A, Leivaditou A, Kostopoulos P.    Cronkhite-Canada syndrome associated with a giant cell bone tumor. J Gastrointestin Liver Dis. 2012;21:345.

  90. Octoratou M, Merikas Ε, Malgarinos G, Stanciu C, Triantafillidis J.K.   A prospective study of pre-illness diet in newly diagnosed patients with Crohn’s disease. Rev Med Chir Soc Med Nat Iasi. 2012;116:40-9

  91. Karagianni VT, Papalois AE,  Triantafillidis J.K. Nutritional status and nutritional support before and after pancreatectomy for pancreatic cancer and chronic pancreatitis. Indian J Surg Oncol.  2012;3:348-59.

  92. Triantafillidis J.K., Merikas E, Nikolakis D, Papalois AE.    Sedation in gastrointestinal endoscopy: Current issues. World J Gastroenterol. 2013;19:463-81

  93. Triantafillidis J.K., Merikas E, Gikas A.    Psychological factors and stress in inflammatory bowel disease. Expert Rev Gastro-enterol Hepatol. 2013;7:225-38.

  94. Triantafillidis J.K., Gikas A.    Over-time changes of Helicoba-cter pylori infection rate in patients with inflammatory bowel disease. J Crohns Colitis. 2013 Jan 26. 

  95. Triantafillidis J.K., Malgarinos G.    Severe psoriasis preceding diagnosis of large bowel Crohn’s disease for 15 years J Crohns Colitis. 2013;7:e80.

  96. Triantafillidis J.K., Penesis G. Crohn’s disease of the large bowel following diagnosis of chronic lymphoid leukaemia: a case report. J Crohns Colitis.  2013;7:e78-9.

  97. Triantafillidis J.K., Vagianos K,  Rontos I.    Psychotic reaction as a cardinal first clinical manifestation in a patient with Crohn’s disease. J Crohns Colitis.2013;7:e76-7.

  98. Triantafillidis J.K., Durakis S,  Merikas E.    Crohn’s disease of the small bowel, complicated by primary biliary cirrhosis, Hashimoto thyroiditis, and Raynaud’s phenomenon: favorable response of all disorders to adalimumab treatment. Gastroenterol Hepatol Bed Bench. 2013;6:101-5

  99. Triantafillidis J.K., Sevastopoulos S. Ulcerative colitis following dia-gnosis and successful cure of Hodgkin’s disease: description of a case. Ann Gastroenterol. 2013;26:185

  100. Triantafillidis J.K. Ulcerative colitis associated with extranodal marginal zone B-cell thyroid lymphoma of mucosa-associated lymphoid tissue and Hashimoto thyroiditis: description of a case. Ann Gastroenterol. 2013;26:92.

  101. Triantafillidis J.K. Vitiligo aggravated after major surgery for Crohn’s disease: a consequence of severe surgical stress? Ann Gastroenterol. 2013;26:278-279.

  102. Triantafillidis J.K., Gikas A, Merikas E. Treatment of inflammatory bowel disease patients with anti-TNF-α factors and immunosuppressives does not influence the prevalence of Helicobacter pylori infection. Indian J Gastroenterol. 2014;33(4):383–384.

  103. Triantafillidis J.K., Douvi G, Agrogiannis G, Patsouris E, Gikas A, Papalois AE. Effect of mesalamine and prednisolone on TNBS experimental colitis, following various doses of orally administered iron. Biomed Res Int. 2014;2014:648535.

  104. Panteris V, Nikolopoulou S, Lountou A, Triantafillidis J.K.  Diagnostic capabilities of high-definition white light endoscopy for the diagnosis of gastric intestinal metaplasia and correlation with histologic and clinical data. Eur J Gastroenterol Hepatol. 2014;26:594-601.

  105. Triantafillidis J.K., Malgarinos G.Long-term efficacy and safety of otilonium bromide in the management of irritable bowel syndrome: a literature review. Clin Exp Gastroenterol. 2014;7:75-82.

  106. Gikas A, Triantafillidis J.K. The role of primary care physicians in early diagnosis and treatment of chronic gastrointestinal diseases. Int J Gen Med.  2014;7:159-173. 

  107. Triantafillidis J.K., Papalois AE. The role of total parenteral nutrition in inflammatory bowel disease: current aspects. Scand J Gastroenterol. 2014;49:3-14.

  108. Egan L, D’Inca R, Jess T, Pellino G, Carbonnel F, Bokemeyer B, Harbord M, Nunes P, Van der Woude J, Selvaggi F, Triantafillidis J.Κ.    Non-colorectal intestinal tract carcinomas in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (II). J Crohns Colitis. 2014;8:19-30.

  109. J.K. Triantafillidis, Ch. Spyropoulos, A. Rentis, K. Vagianos Development of Crohn’s disease in husband and wife: the role of major psychological stress Ann Gastroenterol. 2014;27

  110. J.K. Triantafillidis, G. Malgarinos, A. Rentis, K. Vagianos    Primary aldosteronism during long-term ulcerative colitis: a diagnostic challenge Ann Gastroenterol. 2014;27

  111. Spyropoulos C, Rentis A, Alexaki E, Triantafillidis J.K., Vagianos C.    Appendiceal mucocele and pseudomyxoma peritonei; the clinical boundaries of a subtle disease.     Am J Case Rep. 2014;15:355–360.

  112. Triantafillidis J.K., Vagianos C, Papalois AE. The role of enteral nutrition in patients with inflammatory bowel disease: current aspects.     Biomed Res Int. 2015;2015:197167.

  113. Triantafillidis J.K., Vagianos C, Malgarinos G.    Colonoscopy in Colorectal Cancer Screening: Current Aspects.    Indian J Surg Oncol. 2015;6(3):237–250.

  114. Triantafyllidi A, Xanthos T, Papalois A, Triantafillidis J.K.  Herbal and plant therapy in patients with inflammatory bowel disease.    Ann Gastroenterol. 2015;28(2):210–220.

  115. Triantafillidis J.K., Triantafyllidi A, Vagianos C, Papalois A.  Favorable results from the use of herbal and plant products in inflammatory bowel disease: evidence from experimental animal studies.Ann Gastroenterol. 2016;29(3):268 281.

  116. Turunen KT, Pletsa V, Georgiadis P, Triantafillidis J.K., Karamanolis D, Kyriacou A.    Impact of β-glucan on the Fecal Water Genotoxicity of Polypectomized Patients.    Nutr Cancer. 2016;68(4):560–567.

  117. Vagianos C, Malgarinos G, Spyropoulos C, Triantafillidis J.K.  Entero-vesical fistulas in CROHN'S disease: A case series report and review of the literature.     Int J Surg Case Rep. 2017;41:477–480.

  118. Kasapidis P, Bassioukas S, Mavrogenis G, G. Tribonias , K.Delis, S. Georgopoulos 6, D. Christodoulou, T. Emmanouil, K. Paraskeva, V. Panteris, A. Papalois, J.K. Triantafillidis, Z. Tsiamoulos, T. Fukuhara, Y. Komeda, H. Kashida Experimental gastric endoscopic submucosal dissection: training in a porcine model.     Ann Gastroenterol. 2017;30(4):446–449.

  119. Triantafillidis J.K., Vagianos C, Gikas A, Korontzi M, Papalois A.  Screening for colorectal cancer: the role of the primary care physician.     Eur J Gastroenterol Hepatol. 2017;29(1):e1–e7.

  120. Triantafillidis J.K., Vagianos C, Agrogiannis G,  A. Gikas, G. Douvi, N. Syrmos, E. Patsouris, A. Papalois. Effect of Infliximab and Adalimumab on Experimental Colitis Following Orally Supplemented Iron.  J Invest Surg. 2017;30(1):6–12.

  121. Papada E, Forbes A, Amerikanou C, L. Torović, N. Kalogeropoulos, C. Tzavara, J. K. Triantafillidis, A. C. Kaliora  Antioxidative Efficacy of a Pistacia Lentiscus Supplement and Its Effect on the Plasma Amino Acid Profile in Inflammatory Bowel Disease: A Randomised, Double-Blind, Placebo-Controlled Trial. Nutrients. 2018;10(11):1779. Published 2018 Nov 16. doi:10.3390/nu10111779.

  122. Gavresea F, Vagianos C, Korontzi M, G. Sotiropoulou,  P. Dadioti, J.K. Triantafillidis, A. E Papalois.     Beneficial effect of synbiotics on experimental colon cancer in rats.      Turk J Gastroenterol. 2018;29(4):494–501.

  123. Panteris V, Vezakis A, Triantafillidis J.K.    Should hot biopsy forceps be abandoned for polypectomy of diminutive colorectal polyps?.     World J Gastro-enterol.2018;24(14):1579–1582.

  124. Papalois AE, Barbatis C, Chrysikos D M. Korontzi, M. Sideris, T. Pittaras, E. Triantafyllidi, A. Nomikos, J.K. Triantafillidis Treatment with Molgramostim (Recombinant Human Granu-locyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats. Biomed Res Int. 2019;2019:8298192. Published 2019  Oct 9. doi:10.1155/2019/8298192

  125. Panteris V, Vasilakis N, Demonakou M, Kornarou E, Ktenas E, Rapti E, Spithakis G, Katopodi K, Horti M, Vgenopoulou S, Triantafillidis J.K., Papalois A, Karantanos P.    Alarming endoscopic data in young and older asymptomatic people: Results of an open access, unlimited age colonoscopic screening for colorectal cancer.    Molecular Clinical Oncology 2020; 12:179-185.

  126. Triantafillidis J.K., Malgarinos G, Vagianos C, Papalois EA.    Synchronous Pancreatic and Rectal Carcinoma in the Same Patient: Case Report and Review of the Literature.    Arch Clin Med Case Rep 2020; 4 (1): 059-064.

  127. Triantafillidis J.K., Papalois EA., Triantafyllidi Eleni.  Development of renal cell carcinoma in a young patient with ileocecal Crohn’s disease under treatment with Infliximab: Case report and review of the literature    Arch Clin Med Case Rep 2020; 4 (1):

  128. Triantafillidis J.K., Tzouvala M., Triantafyllidi E.    Enteral Nutrition Supplemented with Transforming Growth Factor-β, Colostrum, Probiotics, and Other Nutritional Compounds in the Treatment of Patients with Inflammatory Bowel Disease. Nutrients  2020, 12, 1048.

  129. Triantafillidis J.K.,  Thomaidis Th, Papalois A. Terminal ileitis due to Yersinia infection: an underdiagnosed situation Biomed Research Internationsl 2020 [in press].

  130. Thomaidis T, Kallimanis G, May G, Zhou PH, Sivanathan V, Mosko J, Triantafillidis  J.K., Teshima C, Moehler M. “Advances in the endoscopic management of malignant biliary obstruction Annals Gastroenterology 2020 [in press].
     

Analyzing Scans

Καθηγητής

Ιωάννης Κ. Τριανταφυλλίδης

MD, PhD, FEBG, MACG
Γαστρεντερολόγος

  • Αν. Καθηγητής Ιατρικού Πανεπιστημίου Ιασίου, Ρουμανία

  • Τ. Συντονιστής Διευθυντής Γαστρεντερολογικού Τμήματος Κρατικού Νοσοκομείου Νίκαιας

Με περισσότερες από 4 δεκαετίες εμπειρίας και εξειδίκευσης, παραμένουμε στην πρώτη γραμμή για την αντιμετώπιση των παθήσεων του πεπτικού, παρέχοντας ασθενοκεντρική φροντίδα στον πάσχοντα συνάνθρωπο.

Γαστρεντερολόγος Ιωάννης Τριανταφυλλίδής, Καθηγητής Πανεπιστημίου Ιασίου, Ιατρεία Γλυφάδα - Χολοργός

Επικοινωνία - Ιατρεία

METROPOLITAN GENERAL

Λεωφ. Μεσογείων 264, Χολαργός 15562

Τηλ. Ραντεβού: 6944 432917

Ωράριο Ιατρείου:

ΔΕΥ - ΤΕΤ - ΠΑΡ  08:30 - 14:00

κατόπιν ραντεβού

Mediterraneo First Care

Λεωφ. Βουλιαγμένης 85, Γλυφάδα 16674

Τηλ. Ραντεβού: 6944 432917

Ωράριο Ιατρείου:

ΤΡΙ - ΠΕΜ  16:00 - 20:00

κατόπιν ραντεβού

Επικοινωνία με τον Ιατρό:

6944 432917

  • Facebook

Όροι χρήσης
Πολιτική Προστασίας Δεδομένων

Χρησιμοποιούμε Cookies για την καλύτερη περιήγησή σας στο site μας

Αποποίηση Ευθύνης
Οι πληροφορίες που περιέχονται σε καμία περίπτωση δεν υποκαθιστούν την κλινική εξέταση,

την ιατρική διάγνωση, τη θεραπεία, τις συμβουλές ή τις οδηγίες του γιατρού σας

Copyright © 2020 | Athens | Prof. John K. Triantafillidis ® Gastroenterologist

ASSOCIATE PROFESSOR, “GR. T. POPA” UNIVERSITY OF MEDICINE & PHARMACY

Medical Design MS